Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin

被引:62
作者
Oliveira, GA
Dell'Aquila, AM
Masiero, RL
Levy, CE
Gomes, MS
Cui, L
Hiramatsu, K
Mamizuka, EM
机构
[1] Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil
[2] Gen Publ Hosp, Sao Paulo, Brazil
[3] Juntendo Univ, Dept Bacteriol, Tokyo 113, Japan
关键词
D O I
10.1086/501932
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To evaluate the possible presence of vancomycin-resistant Staphylococcus aureus (VRSA) in a Brazilian hospital. DESIGN: Epidemiological and laboratory investigation of nosocomial VRSA. METHODS: 140 methicillin-resistant S aureus strains isolated between November 1998 and October 1999 were screened for susceptibility to vancomycin. The screening was carried out by using brain-heart infusion agar (BHIA) supplemented with 4, 6, and 8 mug/mL of vancomycin. The minimum inhibitory concentration (MIC) determination was carried out as standardized by the National Committee for Clinical Laboratory Standards using the broth macrodilution, agar-plate dilution, and E-test methods. PATIENTS: Hospitalized patients exposed to vancomycin. RESULTS: 5 of the 140 isolates had a vancomycin MIC of 8 mug/mL by broth macrodilution, agar plate dilution, and E-test methods. Four VRSA strains were isolated from patients in a burn unit who had been treated with vancomycin for more than 30 days, and one from an orthopedic unit patient who had received vancomycin treatment for 7 days. Pulsed-field gel electrophoresis characterized four of the VRSA strains as belonging to the Brazilian endemic clone. All five strains were negative for vanA, vanB, and vanC genes by polymerase chain reaction. Transmission electron microscopy of the five strains revealed significantly thickened cell walls. One patient died due to infection caused by the VRSA strain. CONCLUSIONS: This is the first report of isolation of VRSA in Brazil and the first report of isolation of multiple VRSA strains from one facility over a relatively short period of time. This alerts us to the possibility that VRSA may be capable of nosocomial transfer if adequate hospital infection control measures are not taken (Infect Control Hosp Epidemiol 2001;22:443-448).
引用
收藏
页码:443 / 448
页数:6
相关论文
共 35 条
[1]   Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus [J].
Aeschlimann, JR ;
Hershberger, E ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1914-1918
[2]  
[Anonymous], MMWR MORB MORTAL WKL
[3]   Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates [J].
Boyle-Vavra, S ;
Berke, SK ;
Lee, JC ;
Daum, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :272-277
[4]  
*BRIT SOC ANT CHEM, 1991, GUID SENS TEST REP W
[5]  
Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P626
[6]   CHARACTERIZATION OF GLYCOPEPTIDE-RESISTANT ENTEROCOCCI FROM UNITED-STATES HOSPITALS [J].
CLARK, NC ;
COOKSEY, RC ;
HILL, BC ;
SWENSON, JM ;
TENOVER, FC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2311-2317
[7]   Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin [J].
Climo, MW ;
Patron, RL ;
Archer, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1747-1753
[8]   Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 [J].
Cui, LZ ;
Murakami, H ;
Kuwahara-Arai, K ;
Hanaki, H ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2276-2285
[9]  
Ferraz V, 2000, S AFR MED J, V90, P1113
[10]  
GOERING RV, 1993, INFECT CONT HOSP EP, V14, P595